CAPRIOLI, CHIARA
CAPRIOLI, CHIARA
Dipartimento di Oncologia ed Emato-Oncologia
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
2024 C. Ronchini, C. Caprioli, G. Tunzi, F.F. D'Amico, E. Colombo, M. Giani, G. Foti, D. Conconi, M. Lavitrano, R. Passerini, L. Pase, S. Capizzi, F. Mastrilli, M. Alcalay, R. Orecchia, G. Natoli, P.G. Pelicci
High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias
2023 A. Magi, G. Mattei, A. Mingrino, C. Caprioli, C. Ronchini, G. Frigè, R. Semeraro, D. Bolognini, A. Rambaldi, A. Candoni, E. Colombo, L. Mazzarella, P.G. Pelicci
INTEGRATED SINGLE-CELL MUTATION, GENE EXPRESSION AND ISOFORM ANALYSIS TO DECONVOLVE ACUTE MYELOID LEUKEMIA HETEROGENEITY
2022 C. Caprioli
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies
2021 S. Ferrari, C. Caprioli, A. Weber, A. Rambaldi, F. Lussana
Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities
2021 C. Caprioli, I. Nazari, S. Milovanovic, P.G. Pelicci
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome?
2021 B. Fattizzo, F. Serpenti, W. Barcellini, C. Caprioli
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
2020 S. Salmoiraghi, R. Cavagna, P. Zanghi', C. Pavoni, A. Michelato, K. Buklijas, L. Elidi, T. Intermesoli, F. Lussana, E. Oldani, C. Caprioli, P. Stefanoni, G. Gianfaldoni, E. Audisio, E. Terruzzi, L. De Paoli, E. Borlenghi, I. Cavattoni, D. Mattei, A. Scattolin, M. Tajana, F. Ciceri, E. Todisco, L. Campiotti, P. Corradini, N. Fracchiolla, R. Bassan, A. Rambaldi, O. Spinelli
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
2020 C. Caprioli, F. Lussana, S. Salmoiraghi, R. Cavagna, K. Buklijas, L. Elidi, P. Zanghi', A. Michelato, F. Delaini, E. Oldani, T. Intermesoli, A. Grassi, G. Gianfaldoni, F. Mannelli, D. Ferrero, E. Audisio, E. Terruzzi, L. De Paoli, C. Cattaneo, E. Borlenghi, I. Cavattoni, M. Tajana, A.M. Scattolin, D. Mattei, P. Corradini, L. Campiotti, F. Ciceri, M. Bernardi, E. Todisco, A. Cortelezzi, B. Falini, C. Pavoni, R. Bassan, O. Spinelli, A. Rambaldi
Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia
2019 F. Lussana, C. Caprioli, P. Stefanoni, C. Pavoni, O. Spinelli, K. Buklijas, A. Michelato, G. Borleri, A. Algarotti, C. Micò, A. Grassi, T. Intermesoli, A. Rambaldi
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
2016 F. Maura, A. Guidetti, A. Pellegrinelli, A. Dodero, M. Pennisi, C. Caprioli, A. Testi, L. Farina, N. Bolli, L.F. Devizzi, A.D. Cabras, P. Corradini